Patent · US Active

Methods for treating acute acoustic trauma

US8420595B2 · kind B2 · utility

4Cited by
4References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2007
Grant dateApr 16, 2013
Priority date
Expiry dateJun 30, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P39/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The current invention provides methods and compositions for treating sensorineural hearing loss including but not limited to acute acoustic trauma (AAT). The composition includes compounds which function as free radical traps such as phenyl butyl nitrone (PBN), free radical scavengers, such as edaravone, resveratrol, ebselen and iron chelator and compounds from the family of antioxidant compounds including, but not limited to, N-acetylcysteine (NAC), Acetyl-L-Carnitine (ALCAR), glutathione monoethylester, ebselen, D-methionine and carbamathione. The compositions of the current invention may be delivered by injections or orally.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.